Company / EPS (Diluted)
ANI Pharmaceuticals, Inc. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.85
FY2025
5-year range
-$3.40 / $0.85
FY2021-FY2025
Trend
+127.9%
vs FY2024
Sector context
#36 of 204
Health Care
What the data says
ANI Pharmaceuticals, Inc.'s eps (diluted) of $0.85 is higher than 82% of companies in the Health Care sector (FY2025). EPS (Diluted) has fluctuated over the past 10 years, ranging from $-3.40 in FY2021 to $1.32 in FY2017.
Based on SEC 10-K filings.
0.85 in FY2025. Top quartile in the Health Care sector.
Remained stable around $0.85 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 204This company $0.85 Sector average -$0.89
▼
+195.9% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 127.9% year-over-year.
- Ranks #36 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2017.
- Lowest eps (diluted) in the period was in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.85 | +127.9% |
| FY2024 | -$3.05 | -458.8% |
| FY2023 | $0.85 | +127.9% |
| FY2022 | -$3.05 | +10.3% |
| FY2021 | -$3.40 | -80.9% |
| FY2020 | -$1.88 | -1988.9% |
| FY2019 | -$0.09 | -106.9% |
| FY2018 | $1.30 | -1.5% |
| FY2017 | $1.32 | +288.2% |
| FY2016 | $0.34 | +137.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026